1Amelican Thoracic Society.European Respiratory Society ERS.International multi-disciplinary consensus classification of the idiopathic interstitial pneumonias[J].Am J Respir Crit Care Med,2002,165(2):277-304.
2Levert H,Gressier B,Brunet C,et al.Time and concentration dependant influence of dirihromycin on oxidative burst[J].Antibiotics,1999,52(2):127-133.
7Desaki M, Takizawa H, Ohtoshi T, et al.Erythromycin suppresses nuclear factor-kappaB and activator protein-1 activation in human bronchial epithelial cells.Biochem Biophys Res Commun,2000,267:124-128.
8Angel P, Karin M.The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation.Biochim Biophys Acta,1991,1072:129-157.
2Wuyts WA, Willems S, Vos R,et al. Azlthromycin reduces pulmonary fibrosis in a bleomycin mouse model. Exp Lung Res, 2010,36(10) : 602-614.
3Patsenker E, Popov Y, Stickel F,et al. Inhibition of integrin alphavbeta6 on cholangiocytes blocks transforming growth factor- beta activation and retards biliary Gbrosis progTession. Gastroenterology, 2008,135 ( 2 ) : 660-670.
4Bergeron A,Soler P,Kambouchner I,et al. Cytonkin profiles in idiopathic pulmonary fibrosis suggest an important role for TGF- β1 and IL-10. Eur Respir J,2003,22( 1 ) :69-76.
5Saiman L, Anstead M, Mayer-Hamblett N,et al. Effect of azithromycin on pulmonary function in patients with cystic fibrosis uninfected with Pseudomonas aeruginosa: a randomized controlled trial. JAMA,2010,303(17) : 1707-1715.
6Florescu DF, Murphy PJ, Kalil AC. Effects of prolonged use of azithromycin in patients with cystic fibrosis: a meta-analysis. Pulm Pharmacol Ther, 2009, 22 (6) : 467--472.
7Kabra SK, Pawaiya R, Lodha R,et al. Long-term daily high and low doses of azithromycin in children with cystic fibrosis: a randomized controlled trial. J Cyst Fibros, 2010,9( 1 ) : 17-23.
